International French-speaking multicentre practice survey on hepatic hydrothorax (HH) : Results of the "Hep Hep" study among 529 hepatogastroenterologist (HG) or pneumologist (PN) respondents.
J. Cadranel (Creil, France), C. Jacques (Paris, France), I. Ollivier (Caen, France), T. Thevenot (Besançon, France), E. Nguyen-Khac (Amiens, France), C. Bureau (Toulouse, France), M. Allaire (Tours, France), J. Nousbaum (Brest, France), V. Loustaud-Ratti ( Limoges, France), X. Causse (Orléan, France), P. Sogni (Paris, France), B. Hanslik (Montpellier, France), M. Bourlière (Marseille, France), J. Péron (Toulouse, France), N. Ganne-Carrié (Bobigny, France), T. Dao (Caen, France), B. Maitre (Créteil, France), L. Elkrief (Tours, France), C. Raherison (Bordeaux, France), T. Le Magoarou (Creil, France)
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cadranel (Creil, France), C. Jacques (Paris, France), I. Ollivier (Caen, France), T. Thevenot (Besançon, France), E. Nguyen-Khac (Amiens, France), C. Bureau (Toulouse, France), M. Allaire (Tours, France), J. Nousbaum (Brest, France), V. Loustaud-Ratti ( Limoges, France), X. Causse (Orléan, France), P. Sogni (Paris, France), B. Hanslik (Montpellier, France), M. Bourlière (Marseille, France), J. Péron (Toulouse, France), N. Ganne-Carrié (Bobigny, France), T. Dao (Caen, France), B. Maitre (Créteil, France), L. Elkrief (Tours, France), C. Raherison (Bordeaux, France), T. Le Magoarou (Creil, France). International French-speaking multicentre practice survey on hepatic hydrothorax (HH) : Results of the "Hep Hep" study among 529 hepatogastroenterologist (HG) or pneumologist (PN) respondents.. 3303
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus Source: ERJ Open Res, 7 (1) 00529-2020; 10.1183/23120541.00529-2020 Year: 2021
Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008
Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
Applying telemonitoring (TMon) post-admission for COPD, at scale: Preliminary findings from a large European trial Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
COPD in primary care - international survey DSP III (patient population description) Source: Eur Respir J 2004; 24: Suppl. 48, 90s Year: 2004
A review of in-house Video Observed Therapy (VOT) for patients with active tuberculosis(TB), in a London teaching hospital. Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018
Critical review of the current management of pleural infection in a UK district general hospital. Applying the MIST II (multicentre intrapleural sepsis trial) evidence to our current practice Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
More than 50% of patients visit a general practitioner (GP), general physician (Gen P) or a pediatrician (P) in India for respiratory symptoms: Results of a one-day point-prevalence study in 2,04,912 patients across 22 states and 5 union territories in India Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012
Healthcare professionals (HCPs) attitudes towards referring patients to pulmonary rehabilitation (PR); a cross sectional exploratory survey Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Assessment of senior medical students in the field of bronchial asthma. Final results of the study ASSA (2014-2016) Source: International Congress 2019 – Medical education Year: 2019
The Wessex AsThma CoHort (WATCH) difficult asthma study; integrating research into the clinic Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases Year: 2016
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Clinical outcomes of patients with HAP/VAP due to PVL(+) vs. PVL(-) MRSA: Results from the IMPACT-HAP study Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center. Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019
Management of children and young people (CYP) in London with asthma: a clinical audit report. Source: International Congress 2018 – Primary care management of asthma Year: 2018
Anti-tobacco medical advice (amb): differencial study between pneumology (pn)vs. primary care (PC) Source: Eur Respir J 2003; 22: Suppl. 45, 28s Year: 2003
Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021
Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021